Auspherix Pty Ltd is an early stage anti-infectives company developing novel antibiotics to treat resistant bacterial disease.
Auspherix has in-licensed intellectual property from the ithree institute at the University of Technology Sydney (UTS). The Company has used a library screening approach to identify drugs with novel mechanisms of action as antibiotics.
www.auspherix.com